Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Peng Men"'
Publikováno v:
IET Image Processing, Vol 16, Iss 13, Pp 3458-3470 (2022)
Abstract In medical image segmentation, the neural network structure of the U‐Net family has demonstrated sufficient advantages. However, MRI images have different scan parameters and different scan times, resulting in different feature representat
Externí odkaz:
https://doaj.org/article/b15844c7541445c19c9355dcfe417c5d
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background In several cardiovascular outcome trials (CVOTs), empagliflozin (SGLT-2 inhibitor), sitagliptin (DPP-4 inhibitor) and liraglutide (GLP-1 receptor agonist) + standard of care (SoC) were compared to SoC in patients with type 2 diabe
Externí odkaz:
https://doaj.org/article/f96df1105ea940048903c74a504a5c53
Autor:
Xiaotong Li, Qingbian Ma, Jia Yin, Ya’an Zheng, Rongchang Chen, Yuguo Chen, Tianzuo Li, Yuqin Wang, Kehu Yang, Hongjun Zhang, Yida Tang, Yaolong Chen, Hailong Dong, Qinglong Gu, Daihong Guo, Xuehui Hu, Lixin Xie, Baohua Li, Yuzhen Li, Tongyu Lin, Fang Liu, Zhiqiang Liu, Lanting Lyu, Quanxi Mei, Jie Shao, Huawen Xin, Fan Yang, Hui Yang, Wanhua Yang, Xu Yao, Chunshui Yu, Siyan Zhan, Guoqiang Zhang, Minggui Wang, Zhu Zhu, Baoguo Zhou, Jianqing Gu, Mo Xian, Yuan Lyu, Zhengqian Li, Hangci Zheng, Chang Cui, Shuhua Deng, Chao Huang, Lisha Li, Pengfei Liu, Peng Men, Chunli Shao, Sai Wang, Xiang Ma, Qiang Wang, Suodi Zhai
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: For anaphylaxis, a life-threatening allergic reaction, the incidence rate was presented to have increased from the beginning of the 21st century. Underdiagnosis and undertreatment of anaphylaxis are public health concerns.Objective: This
Externí odkaz:
https://doaj.org/article/98118bd2f5e049a59f84df86eedc4d2e
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Conbercept is a new anti-vascular endothelial growth factor (VEGF) drug. Here, we systematically conducted the efficacy, safety, compliance, and pharmacoeconomic evaluation of intravitreal conbercept (IVC) compared with other treatments i
Externí odkaz:
https://doaj.org/article/25eeef20a55f4a9db5180ef7eeb2bca7
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Objectives: The aim of this systematic review is to assess the published cost-effectiveness analyses of aprepitant for patients with chemotherapy-induced nausea and vomiting (CINV).Methods: A systematic literature search was performed on PubMed, EMba
Externí odkaz:
https://doaj.org/article/21a1fa577b4d46128659f56349b0ca06
Publikováno v:
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background Dipeptidyl peptidase-4 inhibitors (DPP-4i) are emerging glucose-lowering agents through interacting with DPP-4 substrate, impact of which on systemic inflammation in type 2 diabetes mellitus (T2DM) remains unknown. This study aime
Externí odkaz:
https://doaj.org/article/88809aaac57f438fbbcffb03f1347007
Publikováno v:
Remote Sensing, Vol 14, Iss 11, p 2527 (2022)
Heterogeneous synthetic aperture radar (SAR) images contain more complementary information compared with homologous SAR images; thus, the comprehensive utilization of heterogeneous SAR images could potentially improve performance for the monitoring o
Externí odkaz:
https://doaj.org/article/3716f55507844e27a052ca0a16f5c074
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy can improve clinical outcomes in the treatment of various tumors, but may also be associated with more adverse events (AEs). We performed a systematic review and meta
Externí odkaz:
https://doaj.org/article/3792004b4df94c32a8b4b89d326f1a98
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-15 (2018)
Abstract Background Amisulpride was introduced into China in 2010 as a second-generation atypical antipsychotic, while olanzapine has been on the market since 1999 as one of the leading treatments for schizophrenia in China. Since more Chinese patien
Externí odkaz:
https://doaj.org/article/37adbd8b2c334325b00f7aef1580b472
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Previous studies have preliminarily identified the non-inferior efficacy for reducing skeletal-related event (SRE) rates between de-escalated (Q12w) and standard (Q3-4w) bone-targeting agents therapy in malignant tumor patients with bone
Externí odkaz:
https://doaj.org/article/4bb65dc1f00e4b2e847d2bdf82094256